Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. Vulsteke C, Adra N, Danchaivijitr P, Sabadash M, et al. N Engl J Med 2026 Feb 18. doi: 10.1056/NEJMoa2511674.

Read + Share

Amedeo Smart

Independent Medical Education

Vulsteke C, Adra N, Danchaivijitr P, Sabadash M, et al. Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. N Engl J Med 2026 Feb 18. doi: 10.1056/NEJMoa2511674.
PMID: 41707170